- Filed
- Nov 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 22.73M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 22.5M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 22.56M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 22.63M sh |
| Stock Repurchased | Q3 2026 · Oct 31, 2025 | $1.59M |
| Stock Repurchased | Q3 2026 · Oct 31, 2024 | $2.63M |
| Dividends Paid | Q3 2026 · Oct 31, 2025 | $23.31M |
| Dividends Paid | Q3 2026 · Oct 31, 2024 | $23.32M |
| Capex | Q3 2026 · Oct 31, 2025 | $3.51M |
| Capex | Q3 2026 · Oct 31, 2024 | $6.37M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2025 | $1.27M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2024 | −$40.63M |
| Cash And Equivalents | Q3 2026 · Oct 31, 2025 | $183.88M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | $208.5M |
| Cash And Equivalents | Q3 2026 · Oct 31, 2024 | $181.55M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $497.45M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $481.33M |
| Stockholders Equity restated | Q3 2026 · Oct 31, 2024 | $491.26M |
| Current Liabilities | Q3 2026 · Oct 31, 2025 | $128.7M |
| Current Liabilities | Q3 2026 · Jan 31, 2025 | $112.96M |
| Current Liabilities restated | Q3 2026 · Oct 31, 2024 | $115.68M |
| Total Liabilities | Q3 2026 · Oct 31, 2025 | $252.01M |
| Total Liabilities | Q3 2026 · Jan 31, 2025 | $245.65M |
| Total Liabilities restated | Q3 2026 · Oct 31, 2024 | $253.3M |
| Current Assets | Q3 2026 · Oct 31, 2025 | $522.02M |
| Current Assets | Q3 2026 · Jan 31, 2025 | $489.94M |
| Current Assets restated | Q3 2026 · Oct 31, 2024 | $501.46M |
| Total Assets | Q3 2026 · Oct 31, 2025 | $751.9M |
| Total Assets | Q3 2026 · Jan 31, 2025 | $729.23M |
| Total Assets restated | Q3 2026 · Oct 31, 2024 | $747.15M |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | $0.42 |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | $0.62 |
| Eps Diluted restated | Q3 2026 · Oct 31, 2024 | $0.21 |
| Eps Diluted restated | Q3 2026 · Oct 31, 2024 | $0.46 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | $0.43 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | $0.63 |
| Eps Basic restated | Q3 2026 · Oct 31, 2024 | $0.22 |
| Eps Basic restated | Q3 2026 · Oct 31, 2024 | $0.46 |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $89.33M |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $243.95M |
| Sga Expense restated | Q3 2026 · Oct 31, 2024 | $90.6M |
| Sga Expense restated | Q3 2026 · Oct 31, 2024 | $244.01M |
| Net Income | Q3 2026 · Oct 31, 2025 | $9.58M |
| Net Income | Q3 2026 · Oct 31, 2025 | $13.99M |
| Net Income restated | Q3 2026 · Oct 31, 2024 | $4.83M |
| Net Income restated | Q3 2026 · Oct 31, 2024 | $10.31M |
| Operating Income | Q3 2026 · Oct 31, 2025 | $11.73M |
| Operating Income | Q3 2026 · Oct 31, 2025 | $16.02M |
| Operating Income restated | Q3 2026 · Oct 31, 2024 | $6.03M |
| Operating Income restated | Q3 2026 · Oct 31, 2024 | $10.79M |
| Gross Profit | Q3 2026 · Oct 31, 2025 | $101.06M |
| Gross Profit | Q3 2026 · Oct 31, 2025 | $259.97M |
| Gross Profit restated | Q3 2026 · Oct 31, 2024 | $96.63M |
| Gross Profit restated | Q3 2026 · Oct 31, 2024 | $254.8M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2025 | $85.08M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2025 | $219.76M |
| Cost Of Revenue restated | Q3 2026 · Oct 31, 2024 | $83.89M |
| Cost Of Revenue restated | Q3 2026 · Oct 31, 2024 | $217.1M |
| Revenue | Q3 2026 · Oct 31, 2025 | $186.13M |
| Revenue | Q3 2026 · Oct 31, 2025 | $479.73M |
| Revenue restated | Q3 2026 · Oct 31, 2024 | $180.52M |
| Revenue restated | Q3 2026 · Oct 31, 2024 | $471.9M |